October 22, 2007

ALISO VIEJO, Calif. – Cianna Medical announced today that 100 patients have been treated with the SAVI™ applicator — a significant milestone for the company and for the breast brachytherapy field.

SAVI is a single-entry, multi-catheter applicator that delivers radiation therapy as part of breast conservation therapy. By using a more precisely targeted dose of radiation, SAVI treats the tissue surrounding the lumpectomy cavity while minimizing radiation dose to healthy tissue. Instead of the six week course of treatment required by whole breast radiation, treatment with the SAVI applicator lasts just five days. This approach is becoming a more widely used alternative to whole breast irradiation.

Breast conservation therapy includes lumpectomy – the surgical removal of the cancerous tissue within the breast plus tissue immediately around the tumor – followed by radiation.

“SAVI is becoming a very important tool in the management of our breast cancer patients, because we can deliver breast brachytherapy to more patients than we could with its predecessor,” said Constantine Mantz, M.D. Dr. Mantz is a radiation oncologist with 21st Century Oncology, which operates 83 radiation therapy centers in 16 states.

“The great advantage of partial breast irradiation is that it expedites the course of radiation therapy that a woman would receive following surgery,” said Dr. Mantz.

“Because SAVI is a multi-catheter device we can exert far greater control over how radiation is delivered in the breast. We have the luxury of being able to place the device very close to the skin or very close to the chest wall and still deliver a safe and effective treatment.”

Radiation treatment after a lumpectomy has traditionally involved irradiation of the entire breast with an external beam. This “whole breast irradiation” exposes more healthy tissue and involves a lengthy treatment course, with radiation delivered five times a week over a six-to-seven week period.

Among the 100 patients already treated with the SAVI applicator is Judy Danz, a software engineer in Arizona who was treated at Arizona Oncology Services. “Things came out better than I could have ever expected,” said Danz. “I could not have expected to finish radiation on Friday and go to work on Monday. I was just floored that it went so well and I got back to normal life so quickly.”

“If I had not chosen the SAVI method and had gone for the six weeks of treatment, I think it would really have worn me down,” said Veronica Walworth of Valley Center, Calif., who was treated at the Moores Cancer Center at the University of California, San Diego. “I’m back playing golf, seeing my friends, and entertaining.”

“We’re very gratified by the enthusiasm about SAVI from radiation oncologists, breast surgeons, physicists, and patients,” said Vicki Clements, Cianna’s Vice President of Marketing. “The evidence continues to support our belief that SAVI is a true advance in breast brachytherapy. That is great news for those of us committed to improving breast cancer treatment.”

About Cianna Medical
Cianna Medical, Inc. is a women’s health company dedicated to the innovative treatment of early-stage breast cancer. The company manufactures and markets the SAVI breast-brachytherapy device, for the delivery of radiation after lumpectomy surgery. The SAVI applicator allows contouring of the radiation dose, and is designed to make the benefits of accelerated partial breast irradiation available to a greater number of women. For more information about the company, call (toll-free) 866-920-9444 or visit www.ciannamedical.com.